DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for aggressive periodontitis — screening already-approved drugs against its 2-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleAggressive periodontitis maps to a 2-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for aggressive periodontitis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
cathepsin C (CTSC) — CTSC is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet 3r,5sdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 3PDF · 1.85 Å · ligand 2,5-dibromo-N-{(3R,5S)-1-[(Z)-iminomethyl]-5-methylpyrrolidin-3-yl}benzenesulfonamide (LXV). Experimental structure, not a prediction.
What the evidence adds up to
The American Academy of Periodontology’s 2000 parameter states that failure to treat aggressive periodontitis appropriately can result in progressive and often rapid loss of periodontal supporting tissues, potentially leading to tooth loss. A 2015 review describes the disease as rapidly progressing and aggressive in nature, leading to destruction of periodontal tissues and loss of teeth, and notes that it is influenced by microbiological, genetic, and host factors. The same review calls for advanced diagnostic techniques to learn about current disease activity and rate of progression, and for strategies to keep the disease under control with proper maintenance.
A 2012 study of patients with generalised aggressive periodontitis found that most subjects complained of missing teeth (85%) and gingival recession (75%), followed by bleeding gums (62%), bad breath (58%), pain or sensitivity (53%), and tooth mobility (53%). All clinical parameters measured affected oral health-related quality of life, with missing teeth, bleeding on probing, mobility, and recession having the most significant impact. The authors concluded that aggressive periodontitis has a deep impact on patients’ quality of life and that clinicians must evaluate patient perceptions when setting treatment plans.
A 2007 case report describes the successful treatment of a single patient with aggressive periodontitis using combined periodontal and implant treatment, including augmentive procedures before implant placement. The report notes that limited data are available on the use of dental implants in patients with aggressive periodontitis, especially when grafting is required. A 2013 paper states that aggressive periodontitis probably results from the mobilisation of tissue-destructive mechanisms common to most periodontal diseases, with unique attributes due to pathogen virulence and host susceptibility factors that permit expression at a relatively younger age.
What is still missing are large, controlled trials comparing treatment regimens specifically in aggressive periodontitis, reliable biomarkers to distinguish active disease from stable disease, and validated protocols for implant placement in these patients that account for their higher risk of refractory disease. The evidence base remains dominated by case reports, reviews, and quality-of-life surveys rather than randomised comparisons with long-term tooth retention as the endpoint.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Journal of Periodontology · 2000 · 109 citations · open access
Parameter on Aggressive Periodontitis
AbstractThe American Academy of Periodontology has developed the following parameter on the treatment of aggressive periodontitis. Patients should be informed of the disease process, therapeutic alternatives, potential complications, expected results, and their responsibility in treatment. Consequences of no treatment should be explained. Failure to treat aggressive periodontitis appropriately can result in progressive and often rapid loss of periodontal supporting tissues. This may have an adverse effect upon prognosis and could result in tooth loss. Given this information, patients (or their parents or guardians, as appropriate) should then be able to make informed decisions regarding their periodontal therapy. J Periodontol 2000;71:867-869.
Journal of the International Clinical Dental Research Organization · 2015 · 19 citations · open access
Aggressive periodontitis: A review
AbstractThe purpose of this review is to highlight the current etiological and therapeutic concepts of aggressive periodontitis which is rapidly progressing and aggressive in nature. It leads to destruction of periodontal tissues and loss of teeth. We need advanced diagnostic techniques to learn about current disease activity and rate of progression. We also require strategies to keep the disease under control with proper maintenance regime and prevent tooth loss, because it can result into complicated prosthetic rehabilitation in a very young patient. The evidence suggests that aggressive periodontitis is influenced by microbiological, genetic, and host factors. This paper reviews clinical, microbiological, immunological, and genetic aspects of pathogenesis of aggressive periodontitis, as well as diagnostic criteria of the disease and appropriate nonsurgical and surgical treatment options.
Combined Periodontal and Implant Treatment of a Case of Aggressive Periodontitis
AbstractAggressive periodontitis renders a great challenge to clinicians with regards to treatment and prosthodontic rehabilitation. A compromised remaining dentition and a tendency toward refractory disease make it difficult to establish a treatment plan that renders an adequate long-term prognosis. Although the use of implants has become a common treatment modality, limited data are available on the use of dental implants in patients with aggressive periodontitis, especially for cases necessitating the use grafting procedures preceding implant placement. In this case report the successful treatment of a patient with aggressive periodontitis by the combined use of periodontal and implant treatment necessitating preceding augmentive procedures is described.
Aggressive periodontitis: how does an understanding of the pathogenesis affect treatment?
AbstractUNLABELLED: Aggressive periodontitis is a relatively rare periodontal condition that can result in significant attachment loss over a short period of time. As the disease is difficult to manage, owing to its rapid progression and severity, a variety of adjuncts have been advocated in its management. The authors outline concepts of the aetiology and pathogenesis of aggressive periodontitis and how the different treatment regimens relate to the current understanding of the disease process. CLINICAL RELEVANCE: There is a wide variety of treatment regimens advocated for the treatment of aggressive periodontitis. General dental practitioners and specialists should be aware of the relative advantages and disadvantages of these and how they relate to the disease process.
Dental Journal of Advance Studies · 2013 · 0 citations · open access
AbstractAggressive periodontitis, which encompasses a number of clinical entities, probably results from the mobilization of tissue"s destructive mechanisms which are common to most forms of periodontal diseases. The unique attributes of the disease process are due to the virulence of the pathogens and the host susceptibility may be due to the heritable or acquired susceptibility factors, which permit expression of periodontitis at a relatively younger age.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
